Skip to main content

Rockefeller Capital Management L.P.

Position in DNLI — Denali Therapeutics Inc.

CIK 1739439 NEW YORK, NY

Position in DNLI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$228,753
-$269,198 QoQ
Shares Held
8,894
-65.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#190
of 290 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 80% Shared 0% None 20%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $307,135,851 across 241 Biotechnology names. DNLI ranks #62 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $228,753 8,894
2026-03-31 $497,951 25,935
2025-09-30 $15,725 1,083
2023-06-30 $262,284 8,888
2023-03-31 $199,826 8,724
2022-12-31 $272,733 9,858
2022-09-30 $363,184 11,834
2022-06-30 $330,498 11,230
2022-03-31 $632,204 19,652
2021-12-31 $734,026 16,458
2021-09-30 $746,609 14,799
2021-06-30 $565,316 7,207
2021-03-31 $250,669 4,390
2020-12-31 $209,400 2,500
2020-09-30 $89,575 2,500